Picture of Tourmaline Bio logo

TRML — Tourmaline Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Talaris Therapeutics Announces First Quarter Results

May 12 (Reuters) - Talaris Therapeutics Inc  TALS.O :
    * TALARIS THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL
RESULTS
AND CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.45

Source text for Eikon:  ID:nGNX1bc4dZ 
Further company coverage:  TALS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tourmaline Bio

See all news